Seeking Alpha

Endocyte launches 4.5M-share offering

  • Endocyte's (ECYT) offering would yield gross proceeds of $121.5M at current levels. Underwriters will have a 675K-share overallotment option. (PR)
  • The drug developer had $159M in cash/investments at the end of 2013, and no debt.
  • ECYT -0.7% AH
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector